Primary Care Psychiatry Integration

A Comprehensive Clinical Guide for Primary Care Providers

📋 Clinical Guide
⏱️ Reading Time: 45 min
🎯 CME Eligible

1. Collaborative Care Model (CoCM)

The Collaborative Care Model (CoCM) represents the gold standard for integrating behavioral health services into primary care. Developed and validated through landmark randomized controlled trials, CoCM has demonstrated 2-6x better outcomes compared to usual care for depression and anxiety disorders.

Evidence Base

Landmark Trials
  • IMPACT Trial (2002): Demonstrated 50% improvement in depression scores at 12 months vs. 19% in usual care. Sustained benefits at 24 months.
  • TEAM Trial: Showed significant improvements in both depression and anxiety outcomes with CoCM implementation.
  • Meta-analyses: Systematic reviews consistently show 2-6x improved response rates and remission rates compared to standard primary care treatment.

Core Structure: The Three Pillars

Role Responsibilities Time Commitment
Primary Care Provider (PCP) Leads care team, initiates treatment, engages patient in behavioral health integration Ongoing
Behavioral Health Care Manager (BHCM) Patient outreach, PHQ-9/GAD-7 administration, treatment adherence monitoring, registry management ~70 min/patient/month initially
Psychiatric Consultant Case review, treatment recommendations, complex medication management guidance ~1-2 hours weekly caseload review

Care Manager Role in Detail

The Behavioral Health Care Manager serves as the operational engine of CoCM:

Psychiatric Consultant Role

Treat-to-Target Approach

Treat-to-Target Protocol: Adjust treatment every 4-6 weeks until the patient achieves remission (PHQ-9 <5, GAD-7 <5) or significant response (≥50% score reduction). Do NOT maintain the same treatment if targets are not met.

Stepped Care Framework

1
Initial Treatment: PCP-initiated SSRI/SNRI + care manager engagement + brief behavioral intervention
2
Week 4-6 Review: If partial response (25-49% improvement), optimize current medication dose
3
Week 8-12: If inadequate response (<25% improvement), psychiatric consultation for medication switch or augmentation
4
Week 16+: Consider specialty referral if treatment-resistant, or intensive psychotherapy if available

2. Missed Diagnosis Rates in Primary Care

Psychiatric conditions are significantly underdetected in primary care settings, leading to years of untreated illness, functional impairment, and increased healthcare utilization.

Detection Gap by Diagnosis

Condition Missed Rate Source Clinical Impact
Major Depressive Disorder 65.9% SIMD Study (2022) Chronic functional decline
Generalized Anxiety Disorder 71-97.8% Kroenke et al. Somatic presentations, excessive testing
Bipolar Disorder 69% Hirschfeld et al. Misdiagnosed as MDD, antidepressant-induced mania
ADHD (Adults) 50%+ Kessler et al. Occupational failure, substance use
PTSD 80-90% Marcus et al. Chronic hyperarousal, avoidance
Substance Use Disorders 70-90% Saitz et al. Missed opportunities for brief intervention

Causes of Underdetection

Consequences of Untreated Psychiatric Illness

Clinical Consequences: Untreated depression doubles healthcare costs, triples cardiac mortality post-MI, and increases suicide risk. Each missed diagnosis represents years of preventable suffering.

3. Screening Integration

Systematic screening with validated instruments is essential for closing the detection gap. The following tools should be integrated into routine primary care workflows.

Depression Screening: PHQ-9

Patient Health Questionnaire-9 (PHQ-9)

Administration Time: 2-3 minutes
Sensitivity: 88% | Specificity: 88%
Validation: Kroenke et al., 2001; multiple RCTs

Score Severity Action
1-4 Minimal Monitor, consider lifestyle interventions
5-9 Mild Watchful waiting, rescreen in 2-4 weeks
10-14 Moderate Treatment plan, consider medication or therapy
15-19 Moderately Severe Active treatment indicated
20-27 Severe Immediate treatment, consider psychiatric referral
Question 9 (Suicidal Ideation): Any score >0 on Item 9 requires immediate suicide risk assessment using the Columbia Protocol (C-SSRS). Document assessment and disposition clearly.

Anxiety Screening: GAD-7

Generalized Anxiety Disorder-7 (GAD-7)

Administration Time: 2-3 minutes
Sensitivity: 89% | Specificity: 82%
Validation: Spitzer et al., 2006

Score Severity Action
0-4 Minimal No immediate action
5-9 Mild Monitor, consider lifestyle interventions
10-14 Moderate Treatment plan indicated
15-21 Severe Active treatment, consider psychiatric referral

Alcohol Screening: AUDIT-C

Scoring: Men ≥4 positive; Women ≥3 positive
Validation: Bush et al., 1998; effective in primary care settings

Drug Use Screening: DAST-10

Cutoff: ≥3 indicates problematic drug use requiring intervention
Administration: Self-administered, takes 2 minutes

Suicide Risk Screening: C-SSRS

Columbia Suicide Severity Rating Scale

Purpose: Distinguishes passive ideation from active suicidal intent
Structure: 6 questions assessing ideation severity, intensity, and behavior

Critical Items:

  • Item 4: Specific plan with intent
  • Item 5: Preparation for attempt
  • Item 6: Previous attempt

Any positive on Items 4-6 = Immediate safety intervention required

Administration Protocols

Tool Frequency Setting Billing Code
PHQ-9 Initial visit + each follow-up Waiting room or exam room 96127 (brief emotional/behavioral assessment)
GAD-7 Initial + prn for anxiety symptoms Same as PHQ-9 96127 (separate from PHQ-9 if distinct)
AUDIT-C Annual or when indicated Self-administered 99408 (screening)
C-SSRS When PHQ-9 Item 9 positive or clinical concern Provider-administered Included in E/M service

EHR Integration

4. Treat vs Refer Algorithm

Primary care providers can safely and effectively manage most uncomplicated depression and anxiety. This algorithm guides appropriate scope of practice decisions.

PCP Treatment Appropriate (Proceed with Confidence)

✓
Uncomplicated Depression: PHQ-9 score 10-19, no psychotic features, no active suicidal ideation
✓
Uncomplicated Anxiety: GAD-7 score 10-14, no panic disorder, no severe avoidance
✓
Straightforward SSRI/SNRI Initiation: First or second medication trial, no significant medical comorbidities
✓
Single Diagnosis: Depression OR anxiety without comorbid personality disorder, substance use, or eating disorder

Refer to Psychiatry (Specialist Required)

!
Severe Depression: PHQ-9 ≥20, functional incapacitation, severe psychomotor changes
!
Active Suicidal/Homicidal Ideation: Any intent, plan, or preparation
!
Psychotic Features: Hallucinations, delusions, severe paranoia
!
Bipolar Disorder Suspicion: History of mania/hypomania, family history, antidepressant-induced activation
!
Complex Polypharmacy: ≥3 psychiatric medications, drug-drug interaction concerns
!
Treatment Resistance: ≥2 failed adequate trials of different medication classes
!
Eating Disorders: Anorexia nervosa, bulimia nervosa requiring specialized care
!
Personality Disorders: Borderline, antisocial, narcissistic requiring specialized psychotherapy

Consider CoCM (Collaborative Care)

When available, CoCM bridges the gap between PCP treatment and specialty referral:

5. Common PCP Prescribing Errors

Primary care providers can significantly improve outcomes by avoiding these frequent prescribing pitfalls.

Error 1: Underdosing

Problem: Starting at low dose and maintaining indefinitely without titration.
Example: Sertraline 25mg continued for months, fluoxetine 10mg long-term.
Solution: Start low, titrate to therapeutic dose within 2-4 weeks per guidelines.

Error 2: Premature Switching

Problem: Changing medications before adequate trial duration.
Standard: 8-12 weeks at therapeutic dose before declaring treatment failure.
Solution: Use measurement-based care; if partial response at 6 weeks, optimize dose before switching.

Error 3: Polypharmacy Without Rationale

Problem: Adding medications without discontinuing ineffective ones.
Example: Patient on sertraline 50mg + fluoxetine 20mg + bupropion 150mg without clear indication.
Solution: Simplify regimens; use evidence-based augmentation strategies when indicated.

Error 4: Benzodiazepines as First-Line

Problem: Prescribing alprazolam, lorazepam, or clonazepam as initial anxiety treatment.
Risks: Dependence, cognitive impairment, falls (elderly), rebound anxiety.
Solution: SSRIs/SNRIs are first-line; benzodiazepines only for acute crisis, short-term, with exit plan.

Error 5: Failure to Screen for Bipolar Disorder

Problem: Initiating antidepressants without bipolar screening.
Risk: Antidepressant-induced mania, rapid cycling, treatment resistance.
Solution: Screen with Mood Disorder Questionnaire (MDQ) before starting antidepressants in any patient with recurrent depression.

Error 6: Ignoring Drug-Drug Interactions

Problem: Not checking interactions with warfarin, tramadol, tramadol, tamoxifen, or other serotonergic agents.
Critical Interactions:
  • Fluoxetine/paroxetine + tamoxifen (reduces efficacy)
  • SSRI/SNRI + tramadol (serotonin syndrome risk)
  • SSRI + NSAIDs/aspirin (bleeding risk)
  • Any serotonergic combination (serotonin syndrome)

Error 7: Not Using Measurement-Based Care

Problem: Relying on subjective "How are you feeling?" rather than validated instruments.
Solution: Administer PHQ-9/GAD-7 at every visit; document scores in treatment notes.

Error 8: Inadequate Documentation

Problem: Vague notes without specific symptoms, risk assessment, or treatment rationale.
Solution: Document PHQ-9/GAD-7 scores, specific target symptoms, informed consent, follow-up plan.

Error 9: Inadequate Follow-Up

Problem: Initiating medication without scheduled follow-up.
Solution: See patients at 2 weeks, 4-6 weeks, then every 4-8 weeks until stable.

Error 10: Abrupt Discontinuation

Problem: Stopping SSRIs/SNRIs without taper, especially paroxetine and venlafaxine.
Risk: Discontinuation syndrome (dizziness, nausea, sensory disturbances, anxiety).
Solution: Taper over 2-4 weeks; venlafaxine and paroxetine require slower tapers.

6. Medication Management for PCPs

Selective Serotonin Reuptake Inhibitors (SSRIs)

Sertraline (Zoloft)
50-200 mg daily
Start: 50 mg
Titrate: Increase by 50 mg weekly
Pros: Favorable interaction profile, minimal weight gain
Cons: GI upset initially, dose-related insomnia
Escitalopram (Lexapro)
10-20 mg daily
Start: 10 mg
Titrate: 10→20 mg after 2-4 weeks
Pros: Well-tolerated, effective for anxiety
Cons: QT prolongation at higher doses
Fluoxetine (Prozac)
20-80 mg daily
Start: 20 mg
Titrate: Increase by 20 mg weekly
Pros: Long half-life (missed doses OK), activating
Cons: Long half-life (drug interactions), insomnia, agitation
Paroxetine (Paxil)
20-60 mg daily
Start: 20 mg
Warning: Strong discontinuation syndrome—taper slowly
Pros: Effective for anxiety, sedating option
Cons: Weight gain, sexual side effects, anticholinergic

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Venlafaxine XR (Effexor)
75-225 mg daily
Start: 37.5-75 mg
Titrate: Increase by 75 mg weekly
Pros: Higher doses affect norepinephrine (better for severe depression)
Cons: Significant discontinuation syndrome, hypertension at higher doses
Duloxetine (Cymbalta)
30-120 mg daily
Start: 30-60 mg
Titrate: 30→60 mg after 1-2 weeks
Pros: FDA-approved for chronic pain, diabetic neuropathy
Cons: Hepatic metabolism, nausea initially

Atypical Antidepressants

Bupropion XL (Wellbutrin)
150-450 mg daily
Start: 150 mg AM
Titrate: 150→300 mg after 1 week
Pros: No sexual side effects, weight-neutral, activating
Cons: Lower seizure threshold, contraindicated in eating disorders/seizure disorders, avoid at bedtime
Mirtazapine (Remeron)
15-45 mg nightly
Start: 15 mg at bedtime
Paradox: More sedating at lower doses
Pros: Excellent for insomnia, appetite stimulation (useful in anorexia/cachexia)
Cons: Significant weight gain, daytime sedation

Monitoring Parameters

Medication Class Baseline Labs Follow-Up Monitoring
SSRIs/SNRIs Pregnancy test if applicable PHQ-9/GAD-7 every visit; side effect inquiry
Duloxetine Liver function tests LFTs if symptoms; avoid in hepatic impairment
Bupropion Screen for eating disorder, seizure history Blood pressure; seizure inquiry
Mirtazapine Weight, metabolic panel Weight at each visit; fasting glucose/lipids if weight gain

Discontinuation Guidance

Taper Schedule: Reduce dose by 25-50% every 1-2 weeks for most SSRIs. Venlafaxine and paroxetine require slower tapers due to shorter half-lives and cholinergic rebound. Fluoxetine can often be stopped more quickly due to long half-life.

7. Psychiatric Emergency Recognition

Suicide Risk Assessment: Columbia Protocol (C-SSRS)

C-SSRS Screening Questions
  1. Ideation: "Have you wished you were dead or wished you could go to sleep and not wake up?"
  2. Ideation with Methods: "Have you had any thoughts about killing yourself?"
  3. Intent without Plan: "Have you thought about how you might do this?"
  4. Intent with Plan: "Have you had these thoughts and had some intention of acting on them?"
  5. Preparation: "Have you started to work out the details of how to kill yourself?"
  6. Previous Attempt: "Have you ever done anything, started to do anything, or prepared to do anything to end your life?"

Action Threshold: Positive on Items 4, 5, or 6 = Immediate safety intervention

Acute Psychosis Red Flags

First Break Psychosis: Requires urgent psychiatric evaluation. Rule out medical causes (UTI, medication, substance use) but do not delay psychiatric referral. Young adults presenting with new psychosis may be experiencing first-episode schizophrenia or bipolar disorder.

Mania Recognition: DIGFAST Mnemonic

Letter Symptom Clinical Marker
D Distractibility Attention drawn to irrelevant stimuli
I Indiscretion Impulsive behaviors (spending, sex, substance use)
G Grandiosity Inflated self-esteem, unrealistic plans
F Flight of ideas Racing thoughts, pressured speech
A Activity increase Decreased need for sleep, hypersexuality
S Sleep deficit Feels rested after 2-3 hours sleep
T Talkativeness Pressured, loud, difficult to interrupt
Acute Mania = Emergency: Patients in acute mania have impaired judgment and may cause harm to themselves or others. Requires urgent psychiatric evaluation and often inpatient stabilization.

Panic Attack vs. Cardiac Event

Feature Panic Attack Cardiac Event
Onset Sudden, often at rest With exertion or at rest
Chest Pain Pleuritic, sharp Pressure, heaviness
Duration Peaks in 10 minutes, resolves in 30-60 min Persistent, not time-limited
Paresthesias Common (perioral, extremities) Rare
Troponin Negative Elevated in MI
Clinical Pearl: First-time panic attacks in patients over 40, or those with cardiac risk factors, require ECG and cardiac workup to rule out MI before attributing to anxiety.

Acute Agitation Management

Verbal De-escalation First:

Pharmacological Options (if verbal fails):

Emergency Decision Tree

1
Imminent Danger: Active suicidal intent, command hallucinations, severe agitation with violence risk → Call 911, initiate involuntary hold
2
Acute Psychosis/Mania: Patient cooperative but clearly impaired → Urgent psychiatric evaluation same day
3
Medical Concern: Altered mental status, new neurological signs → ED transfer for medical workup
4
Moderate Risk: Suicidal ideation without plan/intent → Safety plan, close follow-up within 24-48 hours, consider psychiatric consultation

8. Telepsychiatry Models

Telepsychiatry bridges the psychiatric workforce gap, providing primary care access to specialist consultation through various models.

Model Comparison

Model Synchronicity Documentation Patient Contact Typical Response
Curbside Consult Real-time None required No Immediate
eConsult Asynchronous Documented No 3-5 business days
Direct Telepsychiatry Real-time Full visit note Yes Scheduled appointment
Project ECHO Real-time (group) Case-based No Weekly sessions

Curbside Consultation

eConsult (Asynchronous Consultation)

Direct Telepsychiatry

Project ECHO Model

Structure: Hub-and-spoke model connecting academic center (hub) with primary care practices (spokes)

Evidence: Project ECHO has demonstrated improved provider confidence, reduced unnecessary referrals, and improved patient outcomes in multiple chronic conditions including hepatitis C, diabetes, and mental health.

9. Documentation Requirements

Mental Health Parity Compliance

The Mental Health Parity and Addiction Equity Act (MHPAEA) requires that mental health/substance use disorder benefits be no more restrictive than medical/surgical benefits. Documentation must support:

Required Elements in Mental Health Notes

Element Documentation Standard
PHQ-9/GAD-7 Scores Current score, prior score for comparison, trending
Risk Assessment Suicide assessment (even if negative), documented in every visit
Informed Consent Black box warning reviewed (if applicable), side effects discussed
Medication Reconciliation Current medications, adherence, side effects, response
Diagnosis ICD-10 codes with supporting symptoms
Treatment Plan Specific interventions, patient goals, follow-up interval
Time Total visit time; time spent on counseling/coordination if >50%

Suicide Risk Documentation Template

Suicide Risk Assessment:
- Ideation: Denied / Present (describe)
- Plan: None / Vague / Specific (describe)
- Intent: None / Ambivalent / Definite
- Means: Not available / Available but not accessible / Available and accessible
- Protective Factors: [List: family, job, hopefulness, etc.]
- Risk Level: Low / Moderate / High / Imminent
- Safety Plan: Created / Reviewed / NA
- Disposition: Outpatient with follow-up [date] / Safety escort to ED / Voluntary admission

EHR Template Language

Smart Phrase Template
MENTAL HEALTH VISIT
PHQ-9: {{score}}/27 ({{severity}}) | Previous: {{prev_score}}
GAD-7: {{score}}/21 ({{severity}}) | Previous: {{prev_score}}

Suicide Risk: [ ] Denies SI/HI [ ] SI present [ ] HI present
If positive: C-SSRS completed (see separate note)

Medication Adherence: [ ] Good [ ] Partial [ ] Poor
Side Effects: [ ] None [ ] [describe]

Response: [ ] Full remission [ ] Partial response [ ] No response
Plan: [ ] Continue current [ ] Dose increase [ ] Switch to [medication]
Follow-up: [ ] 2 weeks [ ] 4 weeks [ ] 8 weeks

10. Billing and Coding

Collaborative Care CPT Codes

Code Description Requirements Estimated Payment
99492 CoCM initial 70 min First month, BHCM activities, ≥70 min $150-180
99493 CoCM subsequent 60 min Subsequent months, ≥60 min $130-150
99494 CoCM add-on 30 min Additional 30 min increments $60
99495 Interprofessional consult Psychiatrist consultation component $100-140

E/M Codes for Psychiatric Evaluation

Code Description Time (2021+)
99213 Office visit, established, low complexity 20-29 min
99214 Office visit, established, moderate complexity 30-39 min
99215 Office visit, established, high complexity 40-54 min
90791 Psychiatric diagnostic evaluation Typically 60 min
90834 Psychotherapy, 45 minutes 38-52 min

Time-Based Billing

When counseling and coordination of care dominate the visit (>50% of total time), bill based on total time:

Medicare vs. Medicaid Considerations

Medicare: Covers CoCM codes 99492-99494. Requires psychiatric consultant involvement. Patient must have qualifying diagnosis (depression, anxiety, etc.).

Medicaid: Coverage varies by state. Many states have implemented CoCM reimbursement following Medicare model. Verify state-specific guidelines.

11. Liability Considerations

Standard of Care for Psychotropic Prescribing

Primary care providers prescribing psychotropics are held to the same standard as psychiatrists for:

Duty to Warn (Tarasoff Obligations)

Tarasoff Duty: When a patient communicates a serious threat of physical violence against a reasonably identifiable victim, the provider has a duty to protect the victim, including warning them or notifying law enforcement. Laws vary by state.

Involuntary Hold Documentation

When initiating an involuntary hold (Baker Act, 5150, etc.):

Electronic Prescribing for Controlled Substances (EPCS)

Malpractice Risk Reduction

12. Warm Referral Protocols

Warm vs. Cold Referral Show Rates

Referral Type Show Rate Factors
Cold Referral 20-30% Paper referral, patient self-schedules
Warm Handoff 70-80% Introduction made, appointment scheduled
Closed-Loop 90%+ Care manager follows through to first visit

How to Conduct a Warm Handoff

1
Prepare the Patient: Explain why referral is needed and what to expect at the specialist visit
2
Make Contact: Call or message the specialist while patient is present, introduce the case
3
Schedule Appointment: Ideally before patient leaves; confirm date, time, location
4
Written Confirmation: Provide appointment card with all details
5
Send Referral Letter: Transmit records and referral letter immediately

Referral Letter Components

REFERRAL LETTER TEMPLATE

Patient: [Name, DOB, MRN]
Referring Provider: [Name, contact]
Date: [Date]

REASON FOR REFERRAL:
[Brief description of clinical concern]

RELEVANT HISTORY:
- Current Symptoms: [Duration, severity, functional impact]
- Prior Treatments: [Medications tried, response, side effects]
- Current Medications: [List with doses]
- Medical Comorbidities: [Relevant conditions]
- Risk Assessment: [Suicide/violence risk summary]

URGENCY:
[ ] Routine - appointment within 2-4 weeks
[ ] Urgent - appointment within 1 week
[ ] Emergent - please call to discuss

CONTACT:
[Provider name, phone, secure messaging]

Thank you for your collaboration.

Tracking Referral Completion

Closed-Loop Communication

Closed-Loop Requirement: After specialty referral, obtain consultation note and incorporate recommendations into primary care plan. Inform patient of any changes to their care plan. This completes the referral loop and ensures continuity of care.